Current Edition


Pfizer’s big bet on mRNA, Biogen ‘proven wrong’ on Aduhelm price and the next cell therapies

Biotechnology stocks ended the first day of the J.P. Morgan Healthcare Conference in the green, but only barely. By Monday afternoon, a closely followed index of …

Continue Reading →
coronavirus vaccine

CureVac scales back mRNA manufacturing for coronavirus vaccine

While not acknowledged directly, the “corresponding changes in demand” could also stem from disappointing clinical trial results CureVac released for its vaccine in mid-June, which …

Continue Reading →

Merck, Moderna Expand mRNA Cancer Vaccines Partnership

On May 3, 2018, Merck and Moderna Therapeutics, a biotechnology company focused on messenger RNA (mRNA) drug discovery and drug development, announced an expansion of …

Continue Reading →